<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>111Indium-labelled platelets were continuously monitored in the cranial vasculature of anaesthetised rabbits and thrombin inhibitors and anti-coagulants were tested on the sustained platelet accumulation induced by intracarotid injection of thrombin (90 U/kg) </plain></SENT>
<SENT sid="1" pm="."><plain>Pretreatment, commencing 30 min prior to thrombin, with a 1-h intracarotid infusion of <z:chebi fb="0" ids="29996,32500">D-phenylalanyl</z:chebi>-<z:chebi fb="0" ids="32865">L-prolyl</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> chloromethyl <z:chebi fb="3" ids="17087">ketone</z:chebi> (PPACK; 0.25-1.0 micrograms/kg per min), unfractionated <z:chebi fb="5" ids="28304">heparin</z:chebi> (Multiparin; 5-20 U/kg bolus + 0.75-3.0 U/kg per min infusion) or low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> (Fragmin; 2.4-9.6 U/kg per min) produced dose-related reductions in platelet accumulation </plain></SENT>
<SENT sid="2" pm="."><plain>Continuous infusion of <z:chebi fb="9" ids="46887">acetyl</z:chebi>-<z:chebi fb="0" ids="29996,32500">D-phenylalanyl</z:chebi>-<z:chebi fb="0" ids="26274,32874">prolyl</z:chebi>-boroarginine (DuP-714 ester; 30 micrograms/kg per min) for 30 min induced marked accumulation of platelets in the pulmonary circulation in the absence of thrombin </plain></SENT>
<SENT sid="3" pm="."><plain>Bolus intracarotid injection, 1 min before thrombin, of Hirulog (0.05-0.2 mg/kg), PPACK (10-30 micrograms/kg), Multiparin (25-100 U/kg), Fragmin (150 U/kg) or DuP-714 ester (15-30 micrograms/kg) caused significant reductions in platelet accumulation </plain></SENT>
<SENT sid="4" pm="."><plain>When injected 1 min after thrombin, Hirulog (1 mg/kg), PPACK (100 micrograms/kg), Fragmin (150 U/kg) and DuP-714 ester (30 micrograms/kg) had no significant effect and Multiparin (100 U/kg) increased platelet accumulation </plain></SENT>
<SENT sid="5" pm="."><plain>The results demonstrate that pretreatment with a range of thrombin inactivators, acting via different mechanisms, can inhibit thrombin-induced cerebral <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> in the rabbit </plain></SENT>
</text></document>